Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

News Conference News AHA 2022

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

November 06, 2022

PCI Volumes Rise in US and Japan, but for Different Reasons

News Daily News

PCI Volumes Rise in US and Japan, but for Different Reasons

Michael O'Riordan

September 14, 2020

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

News Conference News SCAI 2020

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

May 20, 2020

News Conference News ACC 2020

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

Michael O'Riordan

March 28, 2020

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

News Daily News

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Michael O'Riordan

November 11, 2019

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

News Daily News

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

Yael L. Maxwell

August 15, 2019

TCTMD’s Top 10 Most Popular Stories for September 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

October 02, 2018

News Conference News EuroPCR 2015

PERFECT-2: Angioplasty Can Effectively Treat Erectile Dysfunction But Restenosis an Issue

May 21, 2015

News Daily News

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Yael L. Maxwell

October 25, 2013

ABSORB: Multislice CTA for Noninvasive Assessment of the 18-Month Performance of a Novel Bioresorbable Vascular Scaffolding Device

Presentation

ABSORB: Multislice CTA for Noninvasive Assessment of the 18-Month Performance of a Novel Bioresorbable Vascular Scaffolding Device

Presenter: 53632|Koen Nieman

August 07, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.